Skip to main content
. Author manuscript; available in PMC: 2013 Aug 1.
Published in final edited form as: Curr Opin Pharmacol. 2012 Mar 30;12(4):491–496. doi: 10.1016/j.coph.2012.03.002

Table 1.

Fibrocyte Marker Expression

Marker Expression
Adhesion and Motility
CD9, CD11a, CD11b, CD11c, CD43,
CD164, Mac2, LSP-1
+/++
CD34 +
CD29, CD44, CD81, ICAM-1, CD49
complex, CD81
+

Cell Surface Enzymes

CD10, CD172a +
CD13, Prolyl-4-hydroxylase +
FAP +

Scavenging receptors and host
defense

CD14, CD68, CD163, CD206,
CD209, CD35, CD36
+/−

Fcγ receptors

CD16, CD32a, CD32b, CD32c +/++

Chemokine receptors

CCR2, CCR5, CCR4, CCR7, CCR9,
CXCR1, CXCR4, CXC3R1
+/++

Antigen Presentation

CD80, CD86, MHCI, MCHII +

Extracellular matrix

Collagen-I/III/IV, vimentin, tenascin +
Fibronectin, α-SMA +/−
Collagen V ++

Glycosaminoglycans
Perlecan, Veriscan, Hyaluronan ++/+
Decorin +
Miscellaneous

Semaphorin 7a +
CD115
Thy1.1 +
CD105 +

++ high level, + moderate, +/− conflicting reports or equivocal, - no expression